We can’t show the full text here under this license.
Rates of nausea and vomiting after general anesthesia with remimazolam compared to sevoflurane
Updated
Abstract
The remimazolam group had a 5% incidence of postoperative nausea and vomiting compared to 45% in the sevoflurane group.
- Remimazolam is associated with a significantly lower rate of postoperative nausea and vomiting (PONV) for 24 hours after surgery compared to sevoflurane.
- The use of dexamethasone, a rescue antiemetic, was notably lower in the remimazolam group (0%) compared to the sevoflurane group (30%).
- No significant difference was observed in the Quality of Recovery-15 (QOR-15) score at 24 hours postoperatively between the two groups.
Simplified
Key numbers
5% vs. 45%
PONV Incidence
PONV incidence for remimazolam group vs. sevoflurane group
0% in remimazolam vs. 30% in sevoflurane
Dexamethasone Use
Percentage of patients requiring dexamethasone post-surgery